Literature DB >> 29529670

CORR Insights®: Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.

Anton Khlopas1, Michael A Mont.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29529670      PMCID： PMC6259723          DOI： 10.1007/s11999.0000000000000109

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  10 in total

1.  Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Authors:  Vincent Lo Re; Jessica Volk; Craig W Newcomb; Yu-Xiao Yang; Cristin P Freeman; Sean Hennessy; Jay R Kostman; Pablo Tebas; Mary B Leonard; A Russell Localio
Journal:  Hepatology       Date:  2012-10-14       Impact factor: 17.425

2.  Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study.

Authors:  Qais Naziri; Matthew R Boylan; Kimona Issa; Lynne C Jones; Harpal S Khanuja; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

3.  Does Hepatitis C Affect the Clinical and Patient-Reported Outcomes of Primary Total Hip Arthroplasty at Midterm Follow-Up?

Authors:  Kimona Issa; Todd P Pierce; Steven F Harwin; Anthony J Scillia; Vincent K McInerney; Michael A Mont
Journal:  J Arthroplasty       Date:  2017-04-11       Impact factor: 4.757

4.  Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty?

Authors:  M Winkelmann; J-N Sorrentino; M Klein; C Macke; P Mommsen; S Brand; C Schröter; C Krettek; C Zeckey
Journal:  Orthop Traumatol Surg Res       Date:  2016-04-06       Impact factor: 2.256

5.  The Impact of Hepatitis C on Short-Term Outcomes of Total Joint Arthroplasty.

Authors:  Kimona Issa; Matthew R Boylan; Qais Naziri; Dean C Perfetti; Aditya V Maheshwari; Michael A Mont
Journal:  J Bone Joint Surg Am       Date:  2015-12-02       Impact factor: 5.284

6.  ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV.

Authors:  Anu Osinusi; Susanna Naggie; Seerat Poonia; Martin Trippler; Zonghui Hu; Emily Funk; Joerg Schlaak; Dawn Fishbein; Henry Masur; Michael Polis; Shyam Kottilil
Journal:  J Med Virol       Date:  2012-07       Impact factor: 2.327

7.  Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015.

Authors:  B Rossetti; F Bai; A Tavelli; M Galli; A Antinori; F Castelli; G Pellizzer; A Cozzi-Lepri; S Bonora; A d'Arminio Monforte; M Puoti; A De Luca
Journal:  Clin Microbiol Infect       Date:  2017-07-29       Impact factor: 8.067

8.  Outcomes of cementless primary THA for osteonecrosis in HIV-infected patients.

Authors:  Kimona Issa; Qais Naziri; Vijay Rasquinha; Aditya V Maheshwari; Ronald E Delanois; Michael A Mont
Journal:  J Bone Joint Surg Am       Date:  2013-10-16       Impact factor: 5.284

9.  Prevention and treatment of surgical site infection in HIV-infected patients.

Authors:  Lei Zhang; Bao-Chi Liu; Xiao-Yan Zhang; Lei Li; Xian-Jun Xia; Rui-Zhang Guo
Journal:  BMC Infect Dis       Date:  2012-05-14       Impact factor: 3.090

10.  Anti-infective treatment in HIV-infected patients during perioperative period.

Authors:  Baochi Liu; Lei Zhang; Ruizhang Guo; Jinsong Su; Lei Li; Yanhui Si
Journal:  AIDS Res Ther       Date:  2012-11-27       Impact factor: 2.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.